Dubai PR Network, Online Press Release from Dubai and Middle East
 
Government Sector(Government, Legal & Humanity)
Filter PR by
  
Ministry of Health & Prevention Evaluates Innovative Genetic Drug for Blindness Treatment
 
  • The UAE is one of the world’s first countries to get this medicine 
  • Discussion on the registration of 94 pharmaceutical products (including 15 innovative products, 14 biological preparations and 65 generic medicines)
UAE, Dubai, April 3, 2019: The Ministry of Health and Prevention (MoHAP) revealed that a specialized team from the Higher Committee for Drug Registration representing all UAE health authorities, has evaluated an innovative genetic drug for treating blindness resulting from hereditary retinal degeneration. The genetic drug has already been approved and registered.
 
This announcement came during the periodic meeting of the Drug Registration Committee, its companies and its pricing No. 137/19, which was held under the chairmanship of Dr. Mohamed Salim Al Olama, Under-Secretary of the Ministry and Vice Chairman of the Higher Committee for Drug Pricing and Registration and His Excellency Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing. Present at the meeting were also representatives of MOHAP Drug Department and local health authorities.
 
Committee’s Agenda
 
The meeting discussed the technical committee outcomes for registering innovative, biological and similar medicines manufactured locally or internationally.
The total number of those medicines was 94 pharmaceutical products, including 15 innovative products, 14 biological preparations, and 65 generic medicines, in addition to discussing the pricing of 213 drugs among other topics
 
Drug Registration Committee reviewed various applications of international pharmaceutical companies. The main criteria for examining these applications are its positive contribution to the treatment of various diseases in the country.
 
While considering these applications, the committee takes also into account the economics of companies and supporting their activities that contribute to the ministry's efforts in developing the drug sector and providing treatment to patients as soon as possible, by prioritizing the rapid receipt and evaluation of this product category.  
 
Medical Registration Standards and Regulations
 
Al-Amiri affirmed that the UAE took precedence over the registration of medicines in accordance with the standards and regulations that conform to the best international practices. He pointed out that most innovative medicines are registered in the country in conjunction with the innovative countries of these medicines.
 
Al Amiri also stressed the importance of the Ministry's supervision of the pharmaceutical sector, quality and safety of drugs in the UAE, through pharmaceutical registration, drug price adjustments, in addition to conducting the necessary tests of pharmaceutical products in the reference laboratory, as well as, following up on the safety of use in the country through drug vigilance programs. 
 
Adopting a Global Mechanism for Drug Registration
 
With regards to the evaluation of the pharmaceutical product, Al Amiri explained that MoHAP depends on the clinical studies implemented in most countries of the world. 
 
“Developing a new pharmaceutical product usually takes 10 years including laboratory studies, the new product is then tested to check interaction of pharmaceutical compounds with the living organisms and assure their pharmacological movement in terms of absorption, metabolism processes and methods of its excretion. The aim of these tests is to evaluate the side effects and toxicity expected, as well as to determine the effective therapeutic dose, as well as the lower, higher and toxic doses. The drug is then tested on patients according to a controlled clinical plan, then to be submitted to the global bodies to evaluate all studies and to approve its use and put it on the market,” Al Amiri said.
 
It is worth mentioning that UAE is one of the world’s first countries to obtain this drug. This reflects the keenness of the innovative global companies to launch its medicines in the UAE as the world’s first or second country, after being approved by international bodies such as the FDA and EMEA. This also reflects the confidence of those companies in the country's advanced regulations and standards in the pharmaceutical and medical fields and its quick medical registration system.


Posted by : Dubai PR Network Editorial Team
Viewed 5472 times
PR Category : Government, Legal & Humanity
Posted on : Wednesday, April 3, 2019  4:32:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : UAE's intelligent transportation system sector to witness 9....
Next Story : Nominations Announced for Long-Term Visas for Executives in ...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
VARA - 2019 Fall/Winter Collection [8009-Views]
Nursery children gift Eid packages to labourers [5758-Views]
An increase of 36.7% compared to the first quarter [5216-Views]
Eid Al Adha Event Program [5081-Views]
US $859bn Oil, Gas and Petrochemical Projects Underway or Planned in the MENA Region as Gl... [5069-Views]
Dubai Festival City Mall Celebrates Global Independence Days with Exclusive IMAGINE shows [5039-Views]
Eid Gifting [4868-Views]
Turkish Airlines continues its journey to the top with new cabin uniforms [4673-Views]
Alisha Moopen appointed as the Deputy Managing Director of Aster DM Healthcare [4563-Views]
Evonik sticks to full-year outlook despite cooling economy [4490-Views]
Benefits to young people of becoming a freelancer a focus at International Youth Day event [4337-Views]
GEMS Education offers up some expert ways to get your children to read in the late summer ... [4240-Views]
Zulekha Hospital Sharjah Honored With Baby Friendly Hospital (BFHI) Accreditation From Uni... [4240-Views]
Al-Futtaim Toyota delivers strong H1 results [4148-Views]
FireEye Identifies Prolific Chinese Cyber Threat Group [4087-Views]
Eyes of the World on Expo 2020 Dubai [4056-Views]
MoHAP Announces Working Hours at Primary Health Care & Preventive Medicine Centers During ... [4038-Views]
Lenovo Introduces Single-socket Servers, Designed Specifically for Edge and Data-intensive... [3995-Views]
LG Signature Responds to Market Demand for Luxury Appliances With Expanded Lineup [3788-Views]
Show your Nanny some love and treat them to a Complimentary Haircut throughout August and ... [3654-Views]
9th Muslim World Business and Investment Zone to host Jewels of the Muslim World Award and... [3654-Views]
Sharjah Exports Development Center Achieves Record Results in First Half of 2019 [3599-Views]
Express Auto Wash offers festive deals during Eid Al Adha [3453-Views]
New Mimecast Report Reveals Analysis of 67 Billion Rejected Emails [3306-Views]
Introducing Lunette: A Tool to Empower Women [3306-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories